Yoshiyuki Miyamoto

Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.

Kazuhiro Suzuki, Norio Hayashi, Yoshiyuki Miyamoto et al. · PubMed · 1996 · 217 citations

Human Hepatocellular Carcinoma, Oligonucleotide Primers, Pathology +19

Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.

Yoshiyuki Miyamoto, Philip S. Portoghese, A.E. Takemori · Journal of Pharmacology and Experimental Therapeutics · 1993 · 88 citations

Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.

Yoshiyuki Miyamoto, Philip S. Portoghese, A.E. Takemori · Journal of Pharmacology and Experimental Therapeutics · 1993 · 37 citations

Antinociceptive synergism between supraspinal and spinal sites after subcutaneous morphine evidenced by CNS morphine content

Yoshiyuki Miyamoto, N. Morita, Yuji Kitabata et al. · Brain Research · 1991 · 36 citations

Spinal Cord Injury, Health Sciences, Pain Medicine +15

Effects of a Mixture of Peptidase Inhibitors (Amastatin, Captopril and Phosphoramidon) on Met-Enkephalin-, β-Endorphin-, Dynorphin-(l-13)- and Electroacupuncture-Induced Antinociception in Rats

Shiroh Kishioka, Yoshiyuki Miyamoto, Yuko Fukunaga et al. · The Japanese Journal of Pharmacology · 1994 · 33 citations · Full text

Pain Disorders, Pain Medicine, Neuropathic Pain +22